Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02616 CSTONE PHARMA-B
RT Nominal unchange1.960 0.000 (0.000%)
Latest  |  Final  |  Interim
Non-current Assets
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others100,428-4.955%105,664138,379154,16639,367
Land & other Lease Assets30,579-35.898%47,70468,18728,63127,175
Intangible Assets167,206-3.374%173,045159,69970,5396,509
Interests in Asso. & JCEs0--0000
Other Non-current Assets15,612169.219%5,79925,24560,472117,398

313,825-5.535%332,212391,510313,808190,449
Current Assets
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Inventories181,53066.804%108,82822,18861,3630
Trade Receivables179,0943.860%172,43877,133117,5980
Cash & Bank Balances678,856-31.888%996,671558,684742,7243,024,548
Other Current Assets178,794244.829%51,850588,9121,035,960547,755
Assets Held for Sale0--0000

1,218,274-8.386%1,329,7871,246,9171,957,6453,572,303
Current Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Trade Payables245,042-0.542%246,377290,414414,29328,030
S-T Debt & Leases98,324-29.422%139,31344,91843,94811,314
Other Current Liabilities369,831-20.406%464,648611,150474,707687,705
Liab asso w/ Assets Held for Sale0--0000

713,197-16.128%850,338946,482932,948727,049
Net Current Assets505,0775.345%479,449300,4351,024,6972,845,254
Total Assets Less Current Liabilities818,9020.892%811,661691,9451,338,5053,035,703
Non-current Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
L-T Debt & Leases236,3445.447%224,135241,372130,25072,545
Other Non-current Liabilities114,902-12.085%130,6961,2471,2478,698

351,246-1.010%354,831242,619131,49781,243
Capital and Reserves
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
  Share Capital8600.000%860802796787
  Reserves466,7962.374%455,970448,5241,206,2122,953,673
  Others0--0000
Shareholders' Funds467,6562.370%456,830449,3261,207,0082,954,460
Non-controlling Interests0--0000
Others0--0000

467,6562.370%456,830449,3261,207,0082,954,460
Commitments and Contingent Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Commitments----0034,69082,269
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 25/11/2024 08:24
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (¥)RMB 15,699,000
%Change--
EPS / (LPS)RMB 0.010
NBV Per Share (¥)RMB 0.364
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.